Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High PD‐L1 expression in the tumour cells did not correlate with poor prognosis of patients suffering for oral squamous cells carcinoma: A meta‐analysis of the literature
Giuseppe Troiano, Vito Carlo Alberto Caponio, Khrystyna Zhurakivska, et al.
Cell Proliferation (2018) Vol. 52, Iss. 2
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Prognostic significance of CD68+ and CD163+ tumor associated macrophages in head and neck squamous cell carcinoma: A systematic review and meta-analysis
Giuseppe Troiano, Vito Carlo Alberto Caponio, Iolanda Adipietro, et al.
Oral Oncology (2019) Vol. 93, pp. 66-75
Closed Access | Times Cited: 142
<p>M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancer</p>
Lili Cao, Xiaofang Che, Xue-shan Qiu, et al.
Cancer Management and Research (2019) Vol. Volume 11, pp. 6125-6138
Open Access | Times Cited: 113
Prognostic and clinicopathological significance of PD-L1 overexpression in oral squamous cell carcinoma: A systematic review and comprehensive meta-analysis
Daniel Lenouvel, Miguel Ángel González‐Moles, Isabel Ruiz‐Ávila, et al.
Oral Oncology (2020) Vol. 106, pp. 104722-104722
Closed Access | Times Cited: 64
The immune phenotype of tongue squamous cell carcinoma predicts early relapse and poor prognosis
Giuseppe Troiano, Corrado Rubini, Lucrezia Togni, et al.
Cancer Medicine (2020) Vol. 9, Iss. 22, pp. 8333-8344
Open Access | Times Cited: 60
An update of knowledge on PD‐L1 in head and neck cancers: Physiologic, prognostic and therapeutic perspectives
Daniel Lenouvel, Miguel Ángel González‐Moles, Asmae Talbaoui, et al.
Oral Diseases (2019) Vol. 26, Iss. 3, pp. 511-526
Closed Access | Times Cited: 57
PD‐L1 in oral squamous cell carcinoma: A key biomarker from the laboratory to the bedside
Riccardo Nocini, Matteo Vianini, Ilaria Girolami, et al.
Clinical and Experimental Dental Research (2022) Vol. 8, Iss. 3, pp. 690-698
Open Access | Times Cited: 33
The prognostic significance of PD-L1 and PD-1 expression in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis
Zi-Lu Huang, Shan Liu, Guan-Nan Wang, et al.
Cancer Cell International (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 53
Direct comparison of size-dependent versus EpCAM-dependent CTC enrichment at the gene expression and DNA methylation level in head and neck squamous cell carcinoma
Martha Zavridou, Sofia Mastoraki, Αreti Strati, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 44
Cardiotoxicity risk factors with immune checkpoint inhibitors
Zachary Brumberger, Mary Branch, Max W Klein, et al.
Cardio-Oncology (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 23
PD-L1/PD1 Expression, Composition of Tumor-Associated Immune Infiltrate, and HPV Status in Conjunctival Squamous Cell Carcinoma
Priyadharsini Nagarajan, Christian El‐Hadad, Stephen K. Gruschkus, et al.
Investigative Ophthalmology & Visual Science (2019) Vol. 60, Iss. 6, pp. 2388-2388
Open Access | Times Cited: 39
Indoleamine 2,3-dioxygenase 1 and Programmed Cell Death-ligand 1 Co-expression Predicts Poor Pathologic Response and Recurrence in Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy
Sha Zhou, Lei Zhao, Zhaohui Liang, et al.
Cancers (2019) Vol. 11, Iss. 2, pp. 169-169
Open Access | Times Cited: 36
Triptolide suppresses oral cancer cell PD-L1 expression in the interferon-γ-modulated microenvironment in vitro, in vivo, and in clinical patients
Chin‐Shan Kuo, Cheng‐Yu Yang, Chih‐Kung Lin, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 111057-111057
Open Access | Times Cited: 35
CXCL6 fuels the growth and metastases of esophageal squamous cell carcinoma cells both in vitro and in vivo through upregulation of PD‐L1 via activation of STAT3 pathway
Shutao Zheng, Tongxue Shen, Qing Liu, et al.
Journal of Cellular Physiology (2020) Vol. 236, Iss. 7, pp. 5373-5386
Closed Access | Times Cited: 35
The Evolution of Care of Cancers of the Head and Neck Region: State of the Science in 2020
Flora Yan, Hannah M. Knochelmann, Patrick F. Morgan, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1543-1543
Open Access | Times Cited: 34
A pooled analysis of the prognostic value of PD-L1 in melanoma: evidence from 1062 patients
Jing Yang, Meilian Dong, Yifang Shui, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 33
Prognostic Potential of Tumor-Infiltrating Immune Cells in Resectable Oral Squamous Cell Carcinoma
Ana Căruntu, Liliana Moraru, Mihai Lupu, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2268-2268
Open Access | Times Cited: 31
PD-L1/PD-1 Expression in the Treatment of Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders: An Overview of Reviews
Huda Moutaz Asmael Al‐Azzawi, Syed Ameer Hamza, Rita Paolini, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 4, pp. 126-126
Open Access
Circadian (De)regulation in Head and Neck Squamous Cell Carcinoma
Sadia Rahman, Sandra Kraljević Pavelić, Elitza Markova-Car
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 11, pp. 2662-2662
Open Access | Times Cited: 35
Clinical and Biological Significance of PD-L1 Expression Within the Tumor Microenvironment of Oral Squamous Cell Carcinoma
Hideyuki Takahashi, Koichi Sakakura, Yukiko Arisaka, et al.
Anticancer Research (2019) Vol. 39, Iss. 6, pp. 3039-3046
Open Access | Times Cited: 34
PD-L1 and IDO1 expression and tumor-infiltrating lymphocytes in osteosarcoma patients: comparative study of primary and metastatic lesions
Yu Toda, Kenichi Kohashi, Yuichi Yamada, et al.
Journal of Cancer Research and Clinical Oncology (2020) Vol. 146, Iss. 10, pp. 2607-2620
Open Access | Times Cited: 30
Programmed Cell Death Ligand 1 Expression on Immune Cells and Survival in Patients With Nonmetastatic Head and Neck Cancer
Tomáš Blažek, Marek Petráš, Lukáš Knybel, et al.
JAMA Network Open (2023) Vol. 6, Iss. 3, pp. e236324-e236324
Open Access | Times Cited: 10
Targeting Cellular Metabolism Modulates Head and Neck Oncogenesis
Yi-Ta Hsieh, Yi-Fen Chen, Shu‐Chun Lin, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 16, pp. 3960-3960
Open Access | Times Cited: 27
Prognostic and Clinicopathological Role of PD-L1 in Endometrial Cancer: A Meta-Analysis
Ling Lü, Yonghong Li, Rong Luo, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 27
PD-L1 Expression and a High Tumor Infiltrate of CD8+ Lymphocytes Predict Outcome in Patients with Oropharyngeal Squamous Cells Carcinoma
Nora Wuerdemann, Sibel Elif Gültekin, Katharina Pütz, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5228-5228
Open Access | Times Cited: 25
Real-World, Long-Term Outcomes of Nivolumab Therapy for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck and Impact of the Magnitude of Best Overall Response: A Retrospective Multicenter Study of 88 Patients
Takashi Matsuki, Isaku Okamoto, Chihiro Fushimi, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3427-3427
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top